XL-418

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameXL-418
Drug Alias NameXL-418EXEL-9418
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase AKT1 inhibitors70-kDa ribosomal protein S6 kinases inhibitors
Targets70-kDa ribosomal protein S6 kinasesSerine/threonine-protein kinase AKT1
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesExelixis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesExelixis Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A